Skip to main content
. 2008 Jan 29;8:28. doi: 10.1186/1471-2407-8-28

Table 5.

Comparison of P-cadherin expression in different breast cancer subtypes

IBC Non-IBC p-value

n(%) n(%)
Basal cases (ER-,ERBB2-) 18/19(95%) 35/51(69%) 0.05
ERBB2-overexpressing cases 9/13(69%) 32/47(68%) NS
Luminal cases (ER+, PR+) 14/17(82%) 84/197(43%) <0.01